Depression

Probiotics May Help Relieve Depression, Systematic Review Finds
Probiotics taken alone or in combination with prebiotics may help ease depression, according to a systematic review published online in the journal BMJ Nutrition, Prevention & Health.
Repeated Head Impact Linked With Emotional, Cognitive Problems Later in Life
Adults aged 40 years and older who reported a history of repetitive head impact had more symptoms of depression and difficulties in cognitive functioning, compared with those without such a history, according to a study in Neurology.
Several Risk Factors Linked With Postmenopausal Depression
Alcohol consumption, history of a mental disorder, and having 4 or more living children were among several risk factors for postmenopausal depression identified in a new study.
COVID-19 Harming Mental Health Directly and Indirectly
The COVID-19 pandemic is affecting the mental health of patients hospitalized with the virus, the healthcare workers treating them, people with preexisting psychiatric issues, and the general public.
Machine Learning Model Uses Pretreatment Symptoms, EEG to Predict Antidepressant Response
A machine-learning model used pretreatment symptom scores and electroencephalographic measures to reliably predict patients with depression who responded to antidepressant treatment.
Dr. Robin Carhart-Harris on the Power of Psychedelics
Robin Carhart-Harris, PhD, who will speak at the 2020 virtual Psych Congress Elevate conference, discusses the power of psychedelics.
Quiz: Which Antidepressant Is Used in AXS-05?
AXS-05, which significantly improved symptoms of depression in a recent phase 3 trial, combines dextromethorphan and which antidepressant?
Combining Antidepressants When Treating Depression
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
Novel Dextromethorphan-Bupropion Tablet Rapidly Improves Depressive Symptoms
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Cannabinoids Not Justified as Mental Health Treatment, Study Says
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Teen Depression Risk Lower in Close-Knit Families
Teens with positive family relationships may be less likely to develop depression during adolescence or early adulthood, a new study suggests.

Audio

Dr. Rakesh Jain Gives an Update on Glutamate
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
ABC News Podcast Features Psych Congress Faculty
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
A Discussion on the Science of Depression
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top